3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Sarcoma, Ewing
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Gastrointestinal Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
Fluorouracil
9
Oxaliplatin
7
Leucovorin
7
Surveys and Questionnaires
6
Blood Specimen Collection
6
Bevacizumab
6
Specimen Handling
5
Gemcitabine
5
Cetuximab
5
Capecitabine
5
fludarabine
4
aldesleukin
4
Standard of Care
4
Irinotecan
4
Cyclophosphamide
4
Remote Patient Monitoring
3
Radiosurgery
3
Pafolacianine
3
Nivolumab
3
Endoscopic Mucosal Resection
3
Cisplatin
3
130-nm albumin-bound paclitaxel
3
encorafenib
2
Tomography, X-Ray Computed
2
Sunitinib
2
Referral and Consultation
2
Radiotherapy
2
Practice Guidelines as Topic
2
Pemetrexed
2
Magnetic Resonance Spectroscopy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Gastrointestinal Neoplasms
×
romiplostim
×
1 year
×
Clear all
NCT03362177
2026-02-11
RECITE
Amgen
Phase 3
Completed
165 enrolled
22 charts